[在可能治愈的门上:治疗多发性骨髓瘤的创新]
Tünde Tóth1,2, Hussain Alizadeh1
11 Pécsi Tudományegyetem, Klinikai Központ, I. Belgyógyászati Klinika Pécs, Ifjúság útja 13., 7624 Magyarország.
Orvosi hetilap
|June 9, 2024
概括
多发性骨髓瘤治疗的最新进展提供了更好的生存率,但克服耐药性是治愈的关键. 临床试验中的新诊断工具和免疫疗法旨在改善患者的治疗结果,并挑战疾病的不可治愈性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 多发性骨髓瘤治疗已经通过免疫调节药物,蛋白酶体抑制剂和干细胞移植取得了进展.
- 尽管有进展,但这种疾病仍然是无法治愈的,其特点是缓解和复发.
- 克服耐药性和实现持久的反应对于最终治愈至关重要.
研究的目的:
- 对多发性骨髓瘤的当前治疗指南进行审查.
- 总结临床试验中的新型诊断程序和治疗策略.
- 探索改善患者生活质量和生存的新方法.
主要方法:
- 审查当前多发性骨髓瘤治疗指南.
- 来自临床试验的新兴诊断方法和治疗策略的摘要.
- 分析免疫治疗策略对疾病感知的潜在影响.
主要成果:
- 现代诊断技术促进了早期检测,个性化治疗和适应反应的治疗.
- 新的治疗策略正在临床试验中进行研究.
- 早期整合免疫疗法可能会改变多发性骨髓瘤无法治愈的范式.
结论:
- 在多发性骨髓瘤诊断和治疗方面取得了重大进展.
- 需要新的策略来克服耐药性并实现治愈.
- 未来的研究重点是早期检测,个性化医学和免疫治疗,有望挑战多发性骨髓瘤的无法治愈性.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:31Hybridoma Technology
14.6K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.6K
01:22Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324